Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/25618
Title: Sequence of a new Bowman-Birk inhibitor from Torresea acreana seeds and comparison with Torresea cearensis trypsin inhibitor (TcTI2)
Authors: Tanaka, A. S.
Sampaio, M. U.
Mentele, R.
Auerswald, E. A.
Sampaio, CAM
UNIV MUNICH
Universidade Federal de São Paulo (UNIFESP)
Keywords: Leguminosae
protein sequencing
Torresea acreana
serine proteinase inhibitor
Bowman-Birk inhibitor
Issue Date: 1-Aug-1996
Publisher: Plenum Publ Corp
Citation: Journal of Protein Chemistry. New York: Plenum Publ Corp, v. 15, n. 6, p. 553-560, 1996.
Abstract: TaTI (Torresea acreana trypsin inhibitor), a new member of the Bowman-Birk trypsin inhibitor family, was purified from seeds of Torresea acreana, one of the two known species of Torresea, a Brazilian native Leguminosae of the Papilionoideae subfamily. Purification was performed by acetone fractionation, anion-exchange chromatography, and gel filtration. the TaTI appears as M(r) 7000 in SDS-PAGE under reducing conditions. There are 63 amino acid residues present in the TaTI sequence, which was confirmed by mass spectrometry (8388 daltons). the putative reactive sites residues were Lys-15 and Arg-42 at the first and second site, respectively. the antibodies raised against TcTI2, Torresea cearensis trypsin inhibitor 2, showed a cross-reaction with TaTI, but not with other Bowman-Birk inhibitors purified from Leguminosae. the inhibition constants of TaTI and TcTI2 were comparable when measured against trypsin, chymotrypsin, and factor XIIa, but not on plasmin. the latter was tenfold more effectively inhibited by TcTI2 then by TaTI. Neither TaTI nor TcTI2 affects thrombin, plasma kallikrein, or factor Xa.
URI: http://repositorio.unifesp.br/handle/11600/25618
ISSN: 0277-8033
Other Identifiers: http://dx.doi.org/10.1007/BF01908537
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.